Saturday, 26 October 2013

Hope For Cancer Patients

For the first time a potentially noninvasive technique that can distinguish breast cancer subtypes accurately and provide early breast cancer detection has been reported from the Department of Biochemical Engineering at Vanderbilt University, according to Cancer Research Journal, October 2013 Issue.

Hope For Cancer Patients


The technique called Optimal Metabolic Imaging ( OMI ) can differentiate between malignant and normal cells. The key to the ability of the new technique lies in the different frequencies of fluorescence of 'NADH' and 'FAD'. OMI can differentiate between estrogen receptor-positive and estrogen receptor-negative breast cancer cells. This is not possible by existing standerd clinical metabolic techniques.

OMI offers an unprecedented level of accuracy in finding breast cancer at the earliest stage and tracking the treatment more accurately than done before, the report claims.